Anastasios Gianakakos, SVP, COR & Business Dev at Map Pharmaceuticals, holds 0.00 shares in Map Pharmaceuticals (Ticker: MAPP), holds 624.79K shares in MyoKardia (Ticker: MYOK). Most recently, Anastasios Gianakakos ― shares of Map Pharmaceuticals on ― for an estimated value of ―.